Loading...
H-CYTE, Inc.
HCYT•PNK
Healthcare
Biotechnology
$0.99
$-0.01(-0.50%)
H-CYTE, Inc. (HCYT) Company Profile & Overview
Explore H-CYTE, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
H-CYTE, Inc. (HCYT) Company Profile & Overview
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
SectorHealthcare
IndustryBiotechnology
CEOMr. Michael W. Yurkowsky
Contact Information
Company Facts
2 Employees
IPO DateDec 19, 2014
CountryUS